This message contains images. If you don't see images, click here to view.
Advertise in this news brief.




Text Version    RSS    Subscribe    Unsubscribe    Archive    Media Kit           November 26, 2014

Home     About SGO    Education    Membership    Clinical Practice    Public Policy    Blog    Partnerships    Store

 

FDA strengthens warning on tool for fibroid surgeries
The Wall Street Journal
The U.S. Food and Drug Administration warned that the laparoscopic power morcellator shouldn’t be used for most women undergoing surgery to remove uterine growths, a move that is expected to sharply curtail use of the common gynecological tool. The decision was set to take immediate effect and significantly strengthens an earlier FDA recommendation on the device. It comes after nearly a year of debate among gynecologists about morcellators, which were being used in an estimated 50,000 minimally invasive procedures every year to remove growths known as fibroids.
   Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE  




SGO NEWS


Renew membership by end of month
Please remember to renew your SGO membership by the end of November. Member benefits include discounted rates for SGO meetings, access to SGO Connect Ed, mySGO, Career Center and a full network of colleagues in gynecologic oncology.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article


HPV


Scientists develop new way to treat HPV-related cancer
TIME
A drug called cidofovir that’s already used to target viruses could also be used as part of a novel way to treat cervical cancer. In new Phase 1 research presented at an annual Symposium on Molecular Targets and Cancer Therapeutics in Barcelona, Spain, researchers tested cidofovir in tandem with chemotherapy and found that the drug caused shrinkage of cervical cancer tumors in all of the trial participants, and in 80 percent of the patients the tumors disappeared completely. The combination also showed no toxic side effects.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Advertisement
PRODUCT SHOWCASE
  ChemoFx Improves Ovarian Cancer Outcomes
ChemoFx® provides invaluable information to physicians choosing from 20+ equivalent treatment recommendations without prior knowledge of how individual patients may respond. ChemoFx determines platinum resistance in primary ovarian cancer and demonstrates longer overall survival by 14 months in recurrent ovarian cancer, making it instrumental in improving patient outcomes.
 


Study finds provider-focused intervention improves HPV vaccination rates
Infection Control Today
Changing the way doctors practice medicine is difficult, however a new study has shown that combining traditional education with quality improvement and incentives improves human papillomavirus (HPV) vaccination rates in boys and girls. The study, which appears online in the journal Vaccine, has the potential to produce sustained improvements in these vaccination rates.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Human papillomavirus (HPV) vaccines: An interview with Douglas Lowy, MD
National Cancer Institute
Douglas R. Lowy, MD, heads the Laboratory of Cellular Oncology in NCI’s Center for Cancer Research. He and John Schiller, PhD, also of the Laboratory of Cellular Oncology, are recipients of the 2014 National Medal of Technology and Innovation — the nation’s highest honor for technological achievement — for discoveries that enabled the development of vaccines against infection by human papillomaviruses.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE




MORCELLATION


Uterine leiomyosarcoma: Rare tumor in clinical trials
Medscape (Free login required)
In an interview with Medscape, Martee L. Hensley, MD, MSc, a medical oncologist with the Gynecologic Medical Oncology Service, Department of Medicine, at Memorial Sloan Kettering Cancer Center in New York, discussed the lack of presurgical modalities to differentiate benign uterine fibroids from malignancy, the controversy over morcellation, the deficiencies of current staging systems, and the challenges and initiatives undertaken to manage uterine leiomyosarcoma.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


OVARIAN CANCER


Study finds pelvic radiotherapy may benefit ovarian cancer patients
Radiation Therapy News
In a recent study titled “Patterns of Recurrence and Role of Pelvic Radiotherapy in Ovarian Clear Cell Adenocarcinoma” published in the International Journal of Gynecological Cancer, a team of researchers from Loyola University Health System found that pelvic radiotherapy could be beneficial in the treatment of ovarian clear cell adenocarcinoma (CCA), a rare form of ovarian cancer, in women who undergo surgery and subsequent chemotherapy.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


MISS AN ISSUE OF WOMEN'S CANCER NEWS?
Click here
to visit the SGO Women's Cancer News archive page.


New biomarker predicts PARP response in ovarian cancer
Medscape (Free login required)
A novel biomarker has been identified that can predict which women with ovarian cancer will respond to drugs that inhibit poly [ADP-ribose] polymerase (PARP), over and above the women with BRCA1 and BRCA2 mutations who are known responders to this drug class, new research shows. The study was presented at the 26th EORTSC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics in Barcelona, Spain.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


 



Women's Cancer News
Colby Horton, Vice President of Publishing, 469.420.2601
Download media kit

Jessica Taylor, Senior Medical Editor, 202-684-7169  
Contribute news


Inclusion of advertisements does not constitute SGO endorsement of company products or services.

Be sure to add us to your address book or safe sender list so our emails get to your inbox. Learn how.

This edition of the Women's Cancer News was sent to ##Email##. To unsubscribe, click here. Did someone forward this edition to you? Subscribe here — it's free!

Recent issues

Nov. 19, 2014
Nov. 12, 2014
Nov. 5, 2014
Oct. 22, 2014






7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063